The page is the record's research on the issuer — no analyst, no rating, no view. # ARECOR THERAPEUTICS PLC (AIM: AREC) — research page As of 2026-11-06 · uk-cm-kg · record version 1 ## Identity and listing ARECOR THERAPEUTICS PLC is listed on AIM under the ticker AREC, with ISIN GB00BMWLM973 and LEI 98450093D12I3A8DDD58. Its security type on the record is Corporate, its segment is ASQ1, its sector is Pharmaceuticals and Biotechnology [201030], and its jurisdiction is England and Wales (Companies House jurisdiction field). The record holds its status as listed, not halted. ## The disclosure read The record holds 26 filings across 22 filing days in the twelve months to 2026-11-06. The median gap between filing days is 7 days. The latest filing is dated 2026-10-15, 22 days before the record date, and is a regulatory announcement. The AIM median cadence gap is 7.0 days across 594 issuers, and the AIM median latency is 4 days. The Pharmaceuticals and Biotechnology [201030] median cadence gap is 6.0 days across 51 issuers, and its median latency is 4.0 days. ## Auditor The auditor of record is PKF Littlejohn LLP. Its location is not on the record. Auditor changes are not on the record. ## Events and halts Listing, delisting, name change, domicile change and segment move dates are not on the record, because no lifecycle type map is yet in place for this register. The halt flag is listed, not halted. ## Orderability For elective professional client, the signal is ACM-200 and the outcome is determinable. For eligible counterparty, the signal is ACM-200 and the outcome is determinable. The rule version is acm-68000/uk/product-governance-fca-prod-sourcebook/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations pages that were read. ## Open research Three openly published research notes are on the record, all by Trinity Delta: dated 2024-01-24, 2024-03-13 and 2024-07-23. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth No years of the issuer are sealed, and the market's vintage is not sealed. The live record began on 2026-09-11. Sealed years exist in the store for 2021 through 2026 but are not served as of a date, and the as-of door answers not_sealed. ## Sources 13 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (identity.exchange) - https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/AREC (identity.isin) - https://find-and-update.company-information.service.gov.uk/company/13331147 (identity.jurisdiction) - https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei) - https://www.londonstockexchange.com/stock/AREC/arecor-therapeutics-plc/company-page (identity.sector) - https://mcp.uk-cm-kg.ai/events/AIM/AREC (the disclosure lines) - https://marketsecurities.fca.org.uk/officiallist (the halt flag) - https://arecor.com/wp-content/uploads/2025/05/270269-Arecor-Therapeutics-AR-WEB.pdf (the auditor) - https://mcp.uk-cm-kg.ai/book/aio.json (the orderability chapter) - https://arecor.com/wp-content/uploads/2024/07/AREC-Lighthouse-240723.pdf (open research) - https://arecor.com/wp-content/uploads/2024/03/2024-03-13-TRx-co-development-deal-centred-on-oral-GLP-1-product.pdf (open research) - https://arecor.com/wp-content/uploads/2024/01/AREC-Lighthouse-240124.pdf (open research) - https://mcp.uk-cm-kg.ai/record/AIM/AREC (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/uk/AIM/AREC · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp